Each capsule contains: Tramadol hydrochloride 50 mg.
Tramadol hydrochloride has an analgesic effect in all the usual test models for centrally acting analgesic. It is a potent drug and should not be used for minor pain. It does not have anti-inflammatory effect.
Moderate to severe acute and chronic pain, painful diagnostic measures and surgery.
Usual adult dose: 50 to 100 mg every 4 to 6 hours.
Respiratory depression; acute alcoholism; head injuries.
SEFMAL is contraindicated for: All children younger than 12 years of age; Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy.
Patients known to suffer from convulsions should be carefully monitored during treatment with Tramadol hydrochloride.
Avoid the use of SEFMAL in adolescents 12 to 18 years of age who have other risk factors that may increase their sensitivity to the respiratory depressant effects of Tramadol unless the benefits outweigh the risks. Risk factors include conditions associated with hypoventilation, such as postoperative status, obstructive sleep apnea, obesity, severe pulmonary disease, neuromuscular disease, and concomitant use of other medications that cause respiratory depression.
Lactation: Because of the potential for serious adverse reactions, including excess sedation and respiratory depression in a breastfed infant, breastfeeding is not recommended during treatment with SEFMAL.
May occur during therapy: sweating, dizziness, nausea, vomiting, dry mouth and fatigue.
May decrease clearance of Zidovudine; toxicity of either both medications may be potentiated. Morphine (and/or Tramadol hydrochloride) and Diamorphine were effective microsomal enzyme depletors. A study demonstrating that Cimetidine does not alter Morphine disposition in man.
Store at temperature not more than 30°C.
N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain.
Sefmal cap 50 mg
10 × 10's